Normal lymphocyte development but delayed humoral immune response in CD81-null mice

Journal of Experimental Medicine

Volumn 185, Issue 8, 1997, Pages 1505-1510

  Maecker, Holden T ^a   Levy, Shoshana ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; LYMPHOCYTE ANTIGEN; OVALBUMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; EMBRYO; GENE TARGETING; HUMORAL IMMUNITY; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PERITONEAL CAVITY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPLEEN; STEM CELL; T LYMPHOCYTE; THYMOCYTE;

ANIMALS; ANTIBODY FORMATION; ANTIGENS, CD; ANTIGENS, CD19; B-LYMPHOCYTES; CD4-CD8 RATIO; FLOW CYTOMETRY; IMMUNOPHENOTYPING; LYMPHOCYTES; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; SPLEEN; THYMUS GLAND;

EID: 0030948267     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.185.8.1505     Document Type: Article

References (24)

1. Oren, R., S. Takahashi, C. Doss, R. Levy, and S. Levy. 1990. TAPA-1, the target of an antiproliferative antibody, defines a new family of transmembrane proteins. Mol. Cell. Biol. 10:4007-4015.
2. Maecker, H.T., S.C. Todd, and S. Levy. 1997. The tetraspanin superfamily: molecular facilitators. FASEB J. In press.
3. Matsumoto, A.K., D.R. Martin, R.H. Carter, L.B. Klickstem, J.M. Ahearn, and D.T. Fearon. 1993. Functional dissection of the CD21/CD19/TAPA-1/Leu-13 complex of B lymphocytes. J. Exp. Med. 178:1407-1417.
4. Bradbury, L.E., G.S. Kansas, S. Levy, R.L. Evans, and T.F. Tedder. 1992. The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules. J. Immunol. 149:2841-2850.
5. Carter, R.H., and D.T. Fearon. 1992. CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science (Wash. DC). 256:105-107.
6. Secrist, H., S. Levy, R.H. DeKruyff, and D.T. Umetsu. 1996. Ligation of TAPA-1 (CD81) or major histocompatibility complex class II in co-cultures of human B and T lymphocytes enhances interleukin-4 synthesis by antigen-specific CD4+ T cells. Eur. J. Immunol. 26:1435-1442.
7. Boismenu, R., M. Rhein, W.H. Fischer, and W.L. Havran. 1996. A role for CD81 in early T cell development. Science (Wash. DC). 271:198-200.
8. Todd, S.C., S.G. Lipps, L. Crisa, D.R. Salomon, and C.D. Tsoukas. 1996. CD81 expressed on human thymocytes mediates integrin activation and IL-2-dependent proliferation. J. Exp. Med. 184:2055-2060.
9. Tybulewicz, V.L., C.E. Crawford, P.K. Jackson, R.T. Bronson, and R.C. Mulligan. 1991. Neonatal lethality and lymphopenia in mice with a homozygous disruption ot the c-abl proto-oncogene. Cell. 65:1153-1163.
10. Nagy, A., J. Rossant, R. Nagy, W. Abramow-Newerly, and J.C. Roder. 1993. Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc. Natl. Acad. Sci. USA. 90:8424-8428.
11. Joyner, A.L. 1993. Gene targeting: a practical approach. In The Practical Approach Series. D. Rickwood and B.D. Hames, eidtors. Oxford University Press, New York.
12. Coligan, J.E., A.M. Kruisbeek, D.H. Margulies, E.M. Shevach, and W. Strober. 1995. Curr. Prot. Immunol. Wiley, London. 3.1.3-3.1.5, 3.5.10-3.5.11.
13. Maecker, H.T., D.T. Umetsu, R.H. DeKruyff, and S. Levy. 1997. DNA vaccination with cytokine fusion constructs biases the immune response to ovalbumin. Vaccine. In press.
14. Nagira, M., T. Imai, I. Ishikawa, K.I. Uwabe, and O. Yoshie. 1994. Mouse homologue of C33 antigen (CD82), a member of the transmembrane 4 superfamily: complementary DNA, genomic structure, and expression. Cell. Immunol. 157:144-157.
15. Tomlinson, M.G., and M.D. Wright. 1996. Characterisation of mouse CD37: cDNA and genomic cloning. Mol. Immunol. 33:867-872.
16. Andria, M.L., G.S. Barsh, and S. Levy. 1992. Expression of TAPA-1 in preimplantation mouse embryos. Biochem. Biophys. Res. Commun. 186:1201-1206.
17. Engel, P., and T.F. Tedder. 1994. New CD from the B cell section of the Fifth International Workshop on Human Leukocyte Differentiation Antigens. Leuk. Lymphoma. 13(Suppl.): 61-64.
18. Tedder, T.F., L.J. Zhou, and P. Engel. 1994. The CD19/ CD21 signal transduction complex of B lymphocytes. Immunol. Today. 15:437-442.
19. Fearon, D.T., and R.H. Carter. 1995. The CD19/CR2/ TAPA-1 complex of B lymphocytes: linking natural to acquired immunity. Annu. Rev. Immunol. 13:127-149.
20. Engel, P., L.J. Zhou, D.C. Ord, S. Sato, B. Koller, and T.F. Tedder. 1995. Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. Immunity. 3:39-50.
21. Rickert, R.C., K. Rajewsky, and J. Roes. 1995. Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature (Lond.). 376:352-355.
22. Krop, I., A.R. de Fougerolles, R.R. Hardy, M. Allison, M.S. Schlissel, and D.T. Fearon. 1996. Self-renewal of B-1 lymphocytes is dependent on CD19. Eur. J. Imnmnol. 26:238-242.
23. Ahearn, J.M., M.B. Fischer, D. Croix, S. Goerg, M. Ma, J. Xia, X. Zhou, R.G. Howard, T.L. Rothstein, and M.C. Carroll. 1996. Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. Immunity. 4:251-262.
24. Molina, H., V.M. Holers, B. Li, Y. Fung, S. Mariathasan, J. Goellner, J. Strauss-Schoenberger, R.W. Karr, and D.D. Chaplin. 1996. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc. Natl. Acad. Sci. USA. 93:3357-3361.